Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1206-1211

  Kouchakzadeh, Hasan ^a   Shojaosadati, Seyed Abbas ^a   Maghsoudi, Amir ^a   Vasheghani Farahani, Ebrahim ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

5 fluorouracil; BSA nanoparticle; PEGylation optimization; response surface method (RSM)

Indexed keywords

AMINO ACID; BOVINE SERUM ALBUMIN; FLUOROURACIL; NANOPARTICLE; PHOSPHATE BUFFERED SALINE;

ARTICLE; CONCENTRATION (PARAMETERS); DRUG DIFFUSION; DRUG RELEASE; INCUBATION TEMPERATURE; PARTICLE SIZE; PH; PRIORITY JOURNAL; RESPONSE SURFACE METHOD; SEPARATION TECHNIQUE; TEMPERATURE; ZETA POTENTIAL;

ANIMALS; CATTLE; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG CARRIERS; DRUG COMPOUNDING; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SERUM ALBUMIN, BOVINE;

EID: 78649903242     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9487-8     Document Type: Article

References (39)

1. BG Muller H Leuenberger T Kissel 1996 Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique Pharm Res 13 32 37 1:STN:280:DyaK283itFKktw%3D%3D 10.1023/A:1016064930502 8668675 (Pubitemid 26076293)
2. GV Patil 2003 Biopolymer albumin for diagnosis and in drug delivery Drug Dev Res 58 219 247 1:CAS:528:DC%2BD3sXjvVCjs70%3D 10.1002/ddr.10157 (Pubitemid 36555058)
3. M Merodio A Arnedo MJ Renedo JM Irache 2001 Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release Eur J Pharm Sci 12 251 259 1:CAS:528:DC%2BD3cXoslGhtLc%3D 10.1016/S0928-0987(00)00169-X 11113644
4. M Merodio JM Irache F Valamanesh M Mirshahi 2002 Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats Biomaterials 23 1587 1594 1:CAS:528:DC%2BD38XhtFyku78%3D 10.1016/S0142-9612(01)00284-8 11922464 (Pubitemid 34158581)
5. W Lin MC Garnett SS Davis E Schacht P Ferruti L Illum 2001 Preparation and characterization of rose Bengal-loaded surface-modified albumin nanoparticles J Control Release 71 117 126 1:CAS:528:DC%2BD3MXhs1WjsL0%3D 10.1016/S0168-3659(01)00209-7 11245913 (Pubitemid 32195446)
6. H Wartlick K Michaelis S Balthasar K Strebhardt J Kreuter K Langer 2004 Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells J Drug Target 12 461 471 1:CAS:528:DC%2BD2cXhtFSisLfE 10.1080/10611860400010697 15621671 (Pubitemid 39562430)
7. S Dreis F Rothweiler M Michaelis J Cinatl Jr J Kreuter K Langer 2007 Preparation, characterization and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HAS) nanoparticles Int J Pharm 341 207 214 1:CAS:528:DC%2BD2sXot1Cmu7w%3D 10.1016/j.ijpharm.2007.03.036 17478065 (Pubitemid 47088104)
8. C Weber S Reiss K Langer 2000 Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups Int J Pharm 211 67 78 1:CAS:528:DC%2BD3MXosl2htQ%3D%3D 10.1016/S0378-5173(00)00590-1 11137340 (Pubitemid 32008385)
9. A Vonarbourg C Passirani P Saulnier JP Benoit 2006 Parameters influencing the stealthiness of colloidal drug delivery systems Biomaterials 27 4356 4373 1:CAS:528:DC%2BD28XksFyns7g%3D 10.1016/j.biomaterials.2006.03.039 16650890 (Pubitemid 43674179)
10. Dumitriu S. Polymeric biomaterials. New York: Marcel Dekker; 2001.
11. S Stolnik L Illum S Davis 1995 Long-circulating microparticle drug carriers Adv Drug Deliv Rev 16 195 214 1:CAS:528:DyaK2MXpt1amtrk%3D 10.1016/0169-409X(95)00025-3
12. G Pasut FM Veronse 2007 Polymer-drug conjugation, recent achievements and general strategies Prog Polym Sci 32 933 961 1:CAS:528:DC%2BD2sXovFeksLc%3D 10.1016/j.progpolymsci.2007.05.008 (Pubitemid 47198290)
13. H Maeda J Wu T Sawa Y Matsumura K Hori 2000 Tumor vascular permeability and EPR effect in macromolecular therapeutics, a review J Control Release 65 271 284 1:CAS:528:DC%2BD3cXhtl2qsLo%3D 10.1016/S0168-3659(99)00248-5 10699287 (Pubitemid 30122932)
14. H Maeda 2001 The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv Enzyme Regul 41 189 207 1:CAS:528:DC%2BD3MXmtlekt7k%3D 10.1016/S0065- 2571(00)00013-3 11384745 (Pubitemid 32520323)
15. A Gabizon 1995 Liposome circulation time and targeting: implication for cancer chemotherapy Adv Drug Deliv Rev 16 285 294 1:CAS:528:DyaK2MXpt1amt7w%3D 10.1016/0169-409X(95)00030-B
16. VP Torchilin 2006 Multifunctional nanocarriersm Adv Drug Deliv Rev 58 1532 1555 1:CAS:528:DC%2BD28Xht1KmtLbF 10.1016/j.addr.2006.09.009 17092599 (Pubitemid 44822608)
17. AL Klibanov K Maruyama VP Torichilin L Huang 1990 Amphipatic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett 268 235 238 1:CAS:528:DyaK3cXmtFOqtbc%3D 10.1016/0014-5793(90)81016-H 2384160 (Pubitemid 20233874)
18. K Maruyama T Yuda A Okamoto C Ishikura S Kojima M Iwatsuru 1991 Effect of molecular weight in amphipathic polyethyleneglyco on prolonging the circulation time of large unilamellar liposomes Chem Pharm Bull 39 1620 1622 1:CAS:528:DyaK3MXltF2qtLo%3D 1934187
19. J Senior C Delgado D Fisher C Tilcock G Gregoriadis 1991 Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly (ethylene glycol)-coated vesicles Biochim Biophys 1066 77 82 10.1016/0005-2736(91)90337-8
20. TM Allen C Hanse F Martin C Redemann YA Young 1991 Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo Biochem Biophys 1066 29 36 1:CAS:528:DyaK3MXkslyrsr8%3D 10.1016/0005-2736(91)90246-5
21. D Papadjopoulos TM Allen A Gabizon E Mayhew K Matthay SK Huang KD Lee MC Woodle DD Lasic C Redemon 1991 Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficiency Proc Natl Acad Sci U S A 88 11460 11464 10.1073/pnas.88.24.11460
22. FM Veronese G Pasut 2005 PEGylation, successful approach to drug delivery Drug Discov Today 10 21 1451 1458 1:CAS:528:DC%2BD2MXhtFers7rF 10.1016/S1359-6446(05)03575-0 16243265 (Pubitemid 41483874)
23. Naper DH. Polymeric stabilization of colloidal dispersion. New York: Academic; 1983.
24. J Senior C Delgado D Fisher C Tilcock G Gregoriadis 1991 Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly (ethylene glycol)-coated vesicles Biochem Biophys 1062 77 82 1:CAS:528:DyaK3MXht1yqtLw%3D 10.1016/0005-2736(91)90337-8
25. MC Woodle 1993 Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation Chem Phys Lipids 64 249 262 1:CAS:528:DyaK3sXmslyntrc%3D 10.1016/0009-3084(93)90069-F 8242837
26. TM Allen 1994 The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system Adv Drug Deliv Rev 13 285 309 1:CAS:528:DyaK2cXisl2qs7c%3D 10.1016/0169-409X(94)90016-7 (Pubitemid 24065267)
27. A Chonn SC Semple PR Cullis 1991 Separation of large unilamellar liposomes from blood components by a spain column procedure: toward identifying plasma proteins which mediate liposome clearance in vivo Biochem Biophys 1070 215 222 1:CAS:528:DyaK38XmslWntg%3D%3D 10.1016/0005-2736(91)90167-7
28. A Chonn SC Semple PR Cullis 1992 Association of blood proteins with large unilamellar liposomes in vivo: relation to circulation lifetimes J Biol Chem 267 18759 18765 1:CAS:528:DyaK38XltFygsLk%3D 1527006
29. DD Lasic FG Martin A Gabizon SK Huang D Papahadjopoulos 1991 Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times Biochem Biophys 1070 187 192 1:CAS:528:DyaK38Xisl2kug%3D%3D 10.1016/0005-2736(91)90162-2
30. JH Senior 1987 Fate and behavior of liposomes in vivo: a review of controlling factors CRC Crit Rev Ther Drug Carr Syst 3 123 193 1:CAS:528:DyaL2sXptVSitw%3D%3D
31. K Langer S Balthasar V Vogel N Dinauer H Von Briesen D Schubert 2003 Optimization of the preparation process for human serum albumin (HSA) nanoparticles Int J Pharm 257 169 180 1:CAS:528:DC%2BD3sXjtVems74%3D 10.1016/S0378-5173(03)00134-0 12711172 (Pubitemid 36507043)
32. A Maghsoudi SA Shojaosadati E Vasheghani Farahani 2008 5-fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study AAPS PharmSciTech 9 1092 1096 1:CAS:528:DC%2BC3cXovFanur0%3D 10.1208/s12249-008-9146-5 18850275
33. AFSA Habeeb 1966 Determination of free amino groups of protein by trinitrobenzenesulfonic acid Anal Biochem 14 328 338 1:CAS:528: DyaF28XmvFKitg%3D%3D 10.1016/0003-2697(66)90275-2 4161471
34. F Edwards MC Andry MC Levy 1993 Determination of free amino groups content of serum albumin microcapsules using trinitrobenzenesulfonic acid: effect of variations in polycondensation Int J Pharm 96 85 90 10.1016/0378-5173(93)90215-2
35. F Edwards MC Andry MC Levy 1994 Determination of free amino groups content of serum albumin microcapsules: effect of variations in reaction time and in terephthaloyl chloride concentration Int J Pharm 103 253 257 10.1016/0378-5173(94)90175-9 (Pubitemid 24073686)
36. Harris JM. Advanced PEGylation: polyethylene glycol and derivatives for advanced PEGylation, Nektar Transforming Therapeutic Catalog. 2006.
37. Niemeyer CM. Bioconjugation protocols. New Jersey: Humana; 2004.
38. Montgomery DC. Design and analysis of experiments. New York: Wiley; 2005.
39. Minitab Inc. Minitab software version 15. http//minitab.com. (Accessed 10/03/09).